CoreWeave operates as an AI-native cloud provider focused on GPU-accelerated computing for enterprises, AI labs, and tech firms. It runs a fast-growing network of data centers filled with Nvidia GPUs, delivering bare-metal access optimized for AI training and inference. Since its public debut in March 2025, the company has carved out a position as a specialized "neocloud" option alongside the major hyperscalers. Key customers include OpenAI, Meta Platforms, Anthropic, Jane Street, and IBM, with a contracted revenue backlog nearing $100 billion as of March 31, 2026. In my view, this pure-play exposure to AI demand keeps CRWV on many investors' radar.
From a June 22, 2026 close of $111.29, CRWV slid to $79.58 by July 21, marking a roughly 28% decline. The drop was not steady—the steepest move came on July 1–2 with a 14% plunge after Meta's announcement, followed by further pressure through mid-July and a modest recovery in later sessions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the full quarter the picture is even more negative. Starting from $122.54 on April 22, the shares have given back about 35%. An early-May peak above $137 followed strong first-quarter revenue growth of 112% year over year, but those gains faded as debt, interest costs, and competitive questions took hold. The quarterly move has been sharper than the broader tech sector, highlighting stock-specific issues on top of a mixed environment for growth names.
The main catalyst was Meta Platforms' July 1 plan to launch an internal "Meta Compute" unit selling excess AI capacity to outside customers. This directly challenged CoreWeave's model while Meta remains a major client through a $21 billion agreement through 2032. The combination of potential client loss and new competition prompted a quick repricing of the stock.
Other factors added weight. First-quarter results showed interest expense more than doubling year over year to $536 million and a net loss widening to $740 million. CEO Michael Intrator sold roughly $56 million in shares during July under a pre-set Rule 10b5-1 plan, which is legally allowed yet contributed to negative sentiment. Capital-expenditure guidance was lifted to $31–$35 billion for the year, underscoring the heavy investment needed for growth at a time when profitability metrics are drawing more scrutiny.
The broader quarterly weakness reflects a market reassessment of risk across AI infrastructure. After the May rally on revenue beats and backlog strength, attention turned to the cost structure. Long-term debt has risen to around $35 billion, prompting questions about converting the nearly $100 billion backlog into profitable cash flow at scale.
Competition has intensified beyond Meta, with Microsoft, Amazon, and Google continuing heavy spending on their own AI infrastructure. Nvidia's disclosure of a 9.3% stake in rival Nebius further highlighted a crowded field. While demand for GPU capacity stays solid and CoreWeave targets 1.7 gigawatts of active power by year-end, investors now seek clearer signs of sustainable profitability rather than growth alone.
One area I find useful is reviewing real-time signals from specialized platforms. Tickeron's AI Trend Prediction Engine, for instance, offers a way to track momentum across names like CRWV alongside broader sector patterns, helping put price action into context with historical analogs. It is not a crystal ball, but it can surface data points worth weighing against fundamental developments.
The second-quarter earnings release, expected in early August 2026, will be the next focal point. Analysts forecast roughly 108% year-over-year revenue growth to $2.45–$2.6 billion, with attention likely shifting to operating margins, interest-expense trends, and updated backlog numbers. BofA Securities projects Q2 operating margins of 2.4%, below the 2.8% consensus, with expansion to 14.6% by Q4—delivery on that path will matter for sentiment.
Investors will also watch for updates on Meta's cloud plans and any signals from other large customers about building internal capacity. Progress toward the 1.7-gigawatt target and broader macro factors such as interest-rate policy and hyperscaler capex cycles will influence the stock. CoreWeave's demand outlook remains strong, but near-term direction will depend on evidence that revenue growth is improving unit economics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRWV saw its Momentum Indicator move below the 0 level on June 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator turned negative. In of the 17 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for CRWV turned negative on July 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at .
CRWV moved below its 50-day moving average on June 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CRWV entered a downward trend on July 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CRWV's RSI Indicator exited the oversold zone, of 4 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 14 cases where CRWV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.237) is normal, around the industry mean (13.840). P/E Ratio (0.000) is within average values for comparable stocks, (68.949). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.805). CRWV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.023). P/S Ratio (5.834) is also within normal values, averaging (130.582).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CRWV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows